U.S. Capital Wealth Advisors, LLC Viking Therapeutics, Inc. Transaction History
U.S. Capital Wealth Advisors, LLC
- $3.48 Billion
- Q4 2025
A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 69,030 shares of VKTX stock, worth $2.75 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
69,030
Previous 94,165
26.69%
Holding current value
$2.75 Million
Previous $2.4 Million
14.27%
% of portfolio
0.08%
Previous 0.07%
Shares
7 transactions
Others Institutions Holding VKTX
# of Institutions
436Shares Held
66.6MCall Options Held
7.21MPut Options Held
3.87M-
Vanguard Group Inc Valley Forge, PA10MShares$398 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$240 Million0.01% of portfolio
-
State Street Corp Boston, MA4.51MShares$180 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.73MShares$148 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.58MShares$103 Million0.0% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.05B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...